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SYSTEMS AND METHODS FOR 
CORRECTING OPTICAL REFLECTANCE 
MEASUREMENTS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation of, and claims priority to, 
U.S. patent application Ser. No. 12/568,363 entitled "SYS-
TEMS AND METHODS FOR CORRECTING OPTICAL 
REFLECTANCE MEASUREMENTS," filed on Sep. 28, 
2009 now abandoned, which is a continuation of, and claims 
priority to, U.S. patent application Ser. No. 11/411,538 
entitled "SYSTEMS AND METHODS FOR CORRECTING 
OPTICAL REFLECTANCE MEASUREMENTS," filed on 
Apr. 25, 2006 now U.S. Pat. No. 7,616,303, which claims 
priority to U.S. Provisional Application Ser. No. 60/674,379 
entitled "SYSTEMS AND METHODS FOR CORRECTING 
OPTICAL REFLECTANCE MEASUREMENTS," filed on 
Apr. 25, 2005. The entire contents of each of the foregoing 
applications are incorporated herein by reference. 
STATEMENT AS TO FEDERALLY SPONSORED 
RESEARCH 
Funding for the work described herein was provided by the 
National Space Biomedical Research Institute, Grant Num-
ber SMS00403, funded under NASA Cooperative Agreement 
NCC 9-58 and the U.S. Army Congressionally Directed 
Medical Research Program, Grant Number DAMD17-03-1-
0005. The Federal Government may have certain rights in the 
invention. 
TECHNICAL FIELD 
This invention relates to spectrometer systems and meth-
ods, and more particularly to spectrometer systems for reflec-
tance measurements. 
BACKGROUND 
Optical spectroscopy can be used to determine the concen-
tration of chemical species in gaseous, liquid, and solid 
samples. The amount of light absorbed by a particular chemi-
cal species is often linearly related to its concentration 
through Beer's Law, A—EIc, where  is the absorbance of the 
chemical species, a is a constant specific to the chemical, l is 
the path length of light, and c is the concentration of the 
chemical. When incident light with an intensity, I o, is incident 
on the sample, and I is the intensity of light after it has passed 
through a solution containing the chemical to be measured, 
the absorbance is given by A=log (1,/I). 
For nontransparent materials, including complex materials 
such as powders, tablets, natural materials (e.g., soil, agricul-
tural products), blood, skin, and muscle, optical information 
can be collected via diffuse reflectance spectroscopy. In this 
setting, A=(I ... /I R), where I...  is the light reflected from a 
100% diffuse reflectance standard, the equivalent of the inci-
dent light, and IR is the light reflected from the sample under 
study. The concentration of a chemical component in one of 
these complex materials is related to A, though often not 
linearly. More sophisticated mathematical techniques, such 
as, for example, partial least squares regression and other 
multivariate calibration methods are used to determine a rela-
tionship between concentration and absorbance. Once these 
calibration models are derived, they can be used to determine 
chemical composition by measuring absorbance in transmit-
tance or reflectance mode. 
Diffuse reflectance spectroscopy techniques with near 
5 infrared spectroscopy ("NIRS") have been used for the non-
invasive measurement of blood and tissue chemistry in 
human and animal subjects. NIRS (e.g., using a wavelength 
range of about 650-1000 mu) can be used to measure a num-
ber of important medical parameters such as tissue oxygen- 
lo ation, tissue pH, blood hematocrit ("Hct" ), and glucose, but 
its widespread application in medicine has been hindered by 
both the inter- and intra-subject analyte-irrelevant variation in 
tissue overlying as well as inside the structures to be mea- 
15 sured. For example, when diffuse reflectance NIRS is used to 
measure blood hematocrit in muscle or organs, the accuracy 
of the measurements can be affected by absorbance variations 
in layers overlying the muscle or organs (e.g., due to varia-
tions in the thickness of fat and skin layers between different 
20 patients in a patient population or between different locations 
on an individual patient) and/or spectral interference from 
structural variations in muscle and/or organs that are irrel-
evant to the measurements. 
Near infrared light can penetrate through a subject's skin 
25 and bone to provide information on chemical species present 
in blood and underlying tissue. For example, pulse oximetry, 
a ubiquitous hospital monitoring system that measures arte-
rial hemoglobin oxygen saturation, is based on two-wave-
length NIRS. Multi-wavelength NIRS, in combination with 
30 chemometrics (i.e., statistics-based methods of analyzing 
complex spectra), can provide a platform technology for the 
noninvasive measurement of several additional analytes 
present in the blood and tissue. NIRS can provide accurate 
and continuous measurement of medical analytes without the 
35 need to remove a blood or tissue sample from the patient. The 
application of this technique involves shining near infrared 
light onto the skin directly or through a fiber optic bundle and 
measuring the spectrum of the light that is reflected back from 
the blood containing muscle. While near-infrared absorption 
4o by hemoglobin and deoxyhemoglobin has been used to mea-
sure oxygen saturation levels in various tissue beds, multi-
wavelength spectroscopy in combination with additional 
mathematical techniques often is required to measure addi-
tional important blood and tissue analytes. Chemometrics is a 
45 branch of chemistry that provides statistics-based techniques 
to process multi-wavelength spectra such that analyte con-
centration can be calculated from the reflectance spectra 
recorded from complex media such as biological tissue. 
Chemometrics is used to derive a mathematical relation- 
50 ship between relevant portions of the spectra collected from a 
sample and the concentration or amount of the analyte of 
interest in the sample. The relationship between the spectra 
and the chemical concentration can be expressed as a "cali-
bration equation" that can be programmed into a patient 
55 monitor and used to determine analyte concentrations based 
on the measured reflectance spectra. Spectra collected from 
patients can be processed through calibration equations) 
stored in the patient monitor, and the analyte concentration in 
those patients can be reported based on the collected spectra 
6o and the calibration equations. Because the optical reflectance 
technique is noninvasive, the medical measurement can be 
updated as often as spectra are collected, usually on the order 
of a few seconds. The feasibility of using this method has 
been demonstrated on the bench, in animals, and in human 
65 subjects for the assessment of blood hematocrit, glucose, 
cholesterol, electrolytes, lactate, myoglobin saturation, 
muscle pH, and oxygen tension ("P02")' 
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When calibration equations are developed using chemo-
metrics, at least two sets of data are collected. A set of LAIRS 
spectra is recorded approximately simultaneously with an 
independent, reliable measurement of the analyte over the 
entire physiologic and pathophysiologic range. For example, 
if one wanted to develop a calibration equation to determine 
blood hematocrit from measured reflectance spectra, several 
spectra from subjects would be compared with blood samples 
taken from those subjects and analyzed for hematocrit in a 
clinical laboratory. A chemometric technique, such as, for 
example, partial least squares ("PLS") regression can be used 
to identify and correlate portions of the spectrum to the mea-
sured hematocrit. The regression coefficients are used to gen-
erate the calibration equation. 
Then, when subsequent reflectance spectra are collected 
from other patients, the regression coefficients can be com-
bined with the spectra of the other patients to produce the 
LAIRS-determined hematocrit value for the other patients. An 
advantage of using a chemometric technique such as PLS to 
derive a calibration equation, rather than simple linear regres-
sion, is that PLS is adept at establishing correlation between 
spectra and analytes when the analyte spectra are complicated 
by other absorbing species and scattering elements (like cells 
and muscle fibers). 
For the calibration equation to perform accurately on 
patients over a wide range of instrumental and environmental 
conditions and different patient characteristics, the data in the 
calibration data set should cover as wide a range of values as 
possible and should encompass the entire clinically signifi-
cant range. It is also important that the data be collected under 
the type of variable patient conditions that might affect the 
LAIRS spectra. Conditions that affect spectra include variation 
in temperature, water content, and the presence of interfering 
chemical agents used to treat the patient. This helps ensure 
that the calibration equations are accurate when used on 
future subjects, because the effect of the interfering agents is 
modeled as part of the calibration equation. 
Widespread application of LAIRS for medical measurement 
has been hampered by both inter- and intra-subject variation 
in tissue overlying the target tissue, such as muscle, or the 
target organ. Additionally, LAIRS measurement techniques 
have been limited by their inaccurate performance due to 
short-term changes in skin blood flow or due to long-term 
variation in skin source and texture during wound healing. 
SUMMARY 
The invention is based, at least in part, on the discovery that 
when a spectrometer is used to record reflectance spectra 
from a sample, a short distance between the light source used 
to illuminate the sample and the detector used to measure 
reflected light results in recording of spectra that are sensitive 
to features that are relatively close to the surface of the 
sample, while a longer source-detector distance results in 
spectra that are sensitive to both surface features and deeper 
lying (e.g., internal) features of the sample. Correcting spec-
tra recorded with a long source-detector spacing against spec-
tra recorded with a short source-detector spacing can remove 
the spectral features of the overlying features from the spectra 
of the internal, deeper lying features. The spectra can be 
further corrected to remove features that arise from variations 
in optical scattering properties of the internal features that are 
not related to measurements of an analyte of interest in the 
underlying layers. 
Spectra can be recorded using light of different wave-
lengths. For example, the light source can provide light in one 
4 
or more of the near-infrared, infrared, visible, ultraviolet, and 
other regions of the electromagnetic spectrum. 
In a first aspect, the invention features measurement sys-
tems that include: (a) a light source; (b) a detection system; (c) 
5 a set of at least first, second, and third light ports which 
transmits light from the light source to a sample and receives 
and directs light reflected from the sample to the detection 
system, where a distance between the first port and the third 
port corresponds to a first detection distance, a distance 
io between the second port and the third port corresponds to a 
second detection distance, and the first detection distance is 
larger than the second detection distance; and (d) a processor. 
Either (i) the first and second ports are transmitting ports and 
the third port is a receiving port, or (ii) the first and second 
15 ports are receiving ports and the third port is a transmitting 
port. The detection systems generate a first set of data corre-
sponding to the first detection distance and including infor-
mation corresponding to both an internal target within the 
sample and features overlying the internal target, and a sec- 
20 and set of data corresponding to the second detection distance 
and including information corresponding to features overly-
ing the internal target. The processor is configured to remove 
information characteristic of the overlying features from the 
first set of data using the first and second sets of data to 
25 produce corrected information representing the internal tar-
get. 
Embodiments can include any of the following features. 
The set of at least first, second, and third ports can be 
situated on a single probe. The second detection distance can 
3o be between about I mm and about 5 mm, for example, such as 
between about 1.5 mm and about 3.5 mm. The first detection 
distance can be greater than about 10 mm (e.g., greater than 
about 15 mm, greater than about 20 mm, greater than about 30 
mm, greater than about 50 mm). The system can include a 
35 shutter system for controlling whether light from the first or 
second transmitting port illuminates the sample. 
The probe head can include a thermally conductive mate-
rial to dissipate heat from the sample. The system can further 
include a thermally-conductive bridge between light trans- 
40 miffing ports and light receiving ports. 
The light source can provide light in the near-infrared 
region of the electromagnetic spectrum. The light source can 
include at least one of an incandescent light source element, a 
light emitting diode, a laser diode, and a laser. For example, 
45 the light source can include an array of light emitting diodes. 
The detection system can be a spectral detection system, 
the first and second sets of data can include first and second 
sets of spectra, and the processor can remove spectral infor-
mation characteristic of the overlying features from the first 
50 set of spectra using the first and second sets of spectra to 
produce corrected spectral information representing the inter-
nal target. The spectral detection system can include a spec-
trometer configured to receive light and to generate sets of 
spectra from the received light. Alternatively, the spectral 
55 detection system can include a first spectrometer configured 
to receive light from the first receiving port and to generate the 
first set of spectra, and a second spectrometer configured to 
receive light from the second receiving port and to generate 
the second set of spectra. 
60 	 The processor can be configured to remove spectral infor- 
mation from the first set of spectra that is characteristic of 
variations in optical scattering properties of the internal target 
that are unrelated to an analyte of interest therein. The pro-
cessor can be configured to remove spectral information from 
65 the corrected spectral information representing the internal 
target that is characteristic of variations in optical scattering 
properties of the internal target that are unrelated to an analyte 
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of interest therein. The processor can be configured to remove 
spectral information characteristic of the overlying features 
from the first set of spectra using the first and second sets of 
spectra according to the equation 
5 f?_ Rf —RJW7 
where R f
_ 
is a spectrum from the first set of spectra, R f is a 
spectrum from the second set of spectra, w is a weight, "T" 
denotes a matrix transpose operation, and Ro ,,t comprises 
corrected spectral information representing the internal tar- io 
get. The processor can be further configured to normalize the 
first and second sets of spectra with respect to one another 
prior to producing the corrected spectral information. 
The processor can be configured to remove spectral infor-
mation that is characteristic of variations in optical scattering 15 
properties of the internal target from the first set of spectra by 
orthogonalizing the first set of spectra with respect to a set of 
loading vectors of principal components determined from a 
set of spectra from a plurality of samples. The plurality of 
samples can have a property of the internal target within a 20 
selected range. For example, the property of the internal 
target can be a value of an analyte such as pH, hematocrit, 
tissue oxygenation, or another property. The range can be 
selected to facilitate correction and/or analysis of the spectra. 
For example, a selected range for pH can be 7.37±0.001 pH 25 
units 
The processor can be configured to orthogonalize the first 
set of spectra by performing a set of steps that include: (a) 
performing a principal component analysis on a set of cali-
bration spectra to determine a set of loading vectors corre- 30 
sponding to principal components of the calibration spectra; 
(b) determining one or more orthogonalization factors from 
the principal component analysis; (c) forming a loadings 
matrix having at least one dimension equal to the number of 
orthogonalization factors; and (d) orthogonalizing the first set 35 
of spectra with respect to the loadings matrix. 
In another aspect, the invention features methods for cor-
recting information corresponding to an internal target within 
a sample measured by a system having a light source, a 
detection system, and a set of at least first, second, and third 40 
light ports which transmits light from the light source to the 
sample and receives and directs light reflected from the 
sample to the detection system, where a distance between the 
first port and the third port corresponds to a first detection 
distance and a distance between the second port and the third 45 
port corresponds to a second detection distance, where the 
first detection distance is larger than the second detection 
distance, and where either (i) the first and second ports are 
transmitting ports and the third port is a receiving port, or (ii) 
the first and second ports are receiving ports and the third port 50 
is a transmitting port. The methods include: (a) illuminating 
the sample with one or more light ports of the set; (b) detect-
ing the reflected light with the detection system; (c) generat-
ing a first set of data corresponding to the first detection 
distance and including information corresponding to both an 55 
internal target within the sample and features overlying the 
internal target, and a second set of data corresponding to the 
second detection distance and including information corre-
sponding to features overlying the internal target; and (d) 
removing information characteristic of the overlying features 60 
from the first set of data using the first and second sets of data 
to produce corrected information representing the internal 
target. 
Embodiments of the methods can include any of the fol- 
lowing features. 	 65 
The detection system can be a spectral detection system, 
the first and second sets of data can include first and second  
6 
sets of spectra, andremoving information characteristic of the 
overlying features from the first set of data can include remov-
ing spectral information characteristic of the overlying fea-
tures from the first set of spectra using the first and second sets 
of spectra to produce corrected spectral information repre-
senting the internal target. Removing spectral information 
characteristic of overlying features of the sample from the 
first set of spectra can include combining the first and second 
sets of spectra according to the equation 
Rory —R If- ­R  1JW7 
where R f
_ 
is a spectrum from the first set of spectra, R f is a 
spectrum from the second set of spectra, w is a weight, "T" 
denotes a matrix transpose operation, and Ro,,, includes cor-
rected spectral information representing the internal target. 
The methods can further include normalizing the first and 
second sets of spectra relative to one another prior to produc-
ing the corrected spectral information. Normalizing the sets 
of spectra can include applying a polynomial fit between the 
first and second sets of spectra. Coefficients used in the poly-
nomial fit can be derived from first and second sets of spectra 
recorded from one or more reflectance standards. 
The methods can include processing the first set of spectra 
to remove spectral information characteristic of variations in 
optical properties of the internal target that are unrelated to an 
analyte of interest therein. The methods can include process-
ing the corrected spectral information representing the inter-
nal target to remove spectral information that is characteristic 
of variations in optical scattering properties of the internal 
target that are unrelated to an analyte of interest therein. 
Removing spectral information characteristic of variations in 
optical properties of the internal target that are unrelated to an 
analyte of interest therein can include orthogonalizing the 
first set of spectra with respect to a set of loading vectors of 
principal components determined from a set of calibration 
spectra. 
Orthogonalizing the first set of spectra with respect to a set 
of loading vectors can include: (a) performing a principal 
component analysis on a set of calibration spectra to deter-
mine a set of loading vectors corresponding to principal com-
ponents of the set of calibration spectra; (b) determining one 
or more orthogonalization factors from the principal compo-
nent analysis; (c) forming a loadings matrix having at least 
one dimension equal to the number of orthogonalization fac-
tors; and (d) orthogonalizing the first set of spectra with 
respect to the loadings matrix. 
In another aspect, the invention features methods of mea-
suring an analyte in a subject by: (a) generating a set of 
corrected spectra based on reflectance measurements from an 
animal according to the methods disclosed herein; (b) devel-
oping one or more calibration equations based on a relation-
ship between a measurement of the analyte in the animal and 
the set of corrected spectra from the animal; (c) generating a 
set of corrected spectra based on reflectance measurements 
from the subject according to the methods disclosed herein; 
and (d) determining a value of the analyte in the subject based 
on the one or more calibration equations and the set of cor-
rected spectra from the subject. The subject can be a human, 
for example. The sets of corrected spectra can be generated 
based on reflectance measurements from the animal and the 
subject are further processed to remove spectral information 
characteristic of variations in optical properties of internal 
targets comprising the analyte. 
The invention also features methods of measuring an ana-
lyte in a subject by: (a) generating a set of corrected spectra 
based on reflectance measurements from a first body site of 
the subject according to the methods disclosed herein; (b) 
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developing one or more calibration equations based on a 
relationship between a measurement of the analyte at the first 
body site and the set of corrected spectra from the first body 
site; (c) generating a set of corrected spectra based on reflec-
tance measurements from a second body site of the subject 
according to the methods disclosed herein; and (d) determin-
ing a value of the analyte at the second body site based on the 
one or more calibration equations and the set of corrected 
spectra from the second body site. The subject can be a 
human, the first body site can be an arm, and the second body 
site can be a leg. The sets of corrected spectra generated based 
on reflectance measurements from the first and second body 
sites can be further processed to remove spectral information 
characteristic of variations in optical properties of internal 
targets comprising the analyte. 
Unless otherwise defined, all technical and scientific terms 
used herein have the same meaning as commonly understood 
by one of ordinary skill in the art to which this invention 
belongs. Although methods and materials similar or equiva-
lent to those described herein can be used in the practice or 
testing of the present invention, suitable methods and mate-
rials are described below. All publications, patent applica-
tions, patents, and other references mentioned herein are 
incorporated by reference in their entirety. In case of conflict, 
the present specification, including definitions, will control. 
In addition, the materials, methods, and examples are illus-
trative only and not intended to be limiting. 
Other features and advantages of the invention will be 
apparent from the following detailed description, and from 
the claims. 
DESCRIPTION OF DRAWINGS 
FIG. 1 is a schematic diagram of a spectrometer system 
described herein. 
FIG. 2 is a top schematic view of an optical bench and 
selected components of the spectrometer system of FIG. 1. 
FIG. 3 is a schematic diagram of an incandescent lamp. 
FIG. 4A is schematic diagram of an arrangement of two 
fiber optic cables for delivering light to a sample and a fiber 
optic cable for delivering reflected light from the sample to a 
spectrograph. 
FIG. 4B is a schematic end view of an arrangement of fibers 
in the fiber optic cable for delivering light to the sample and 
fibers in the fiber optic cable for delivering reflected light 
from the sample to a spectrograph. 
FIG. 5A is a schematic side view of an embodiment of a 
probe head for delivering light to a sample and for receiving 
reflected light from the sample. 
FIG. 5B is a schematic bottom view of an embodiment of a 
probe head with integrated light sources. 
FIG. 6A is a schematic top view of a light shield for holding 
and shielding the probe head shown in FIG. 5. 
FIG. 6B is a schematic top view of an alternative embodi-
ment of the light shield of FIG. 6A. 
FIG. 7 is a schematic view of a shutter used in the spec-
trometer system of FIG. 1. 
FIG. 8 is a circuit diagram of an electrical circuit for con-
trolling the shutter shown in FIG. 7. 
FIGS. 9A-9E are graphs that show results of a correction to 
remove spectral interference due to overlying layers from 
reflectance spectra measured from a human subject. 
FIGS.1 OA-1 OE are graphs that show results of a correction 
to remove spectral interference due to overlying layers from 
reflectance spectra measured from another human subject. 
8 
FIG. 11 is a graph showing values of maximum heme 
absorbance versus measured blood hematocrit for uncor-
rected spectral data. 
FIG. 12 is a graph showing values of maximum heme 
5 absorbance versus measured blood hematocrit for spectral 
data corrected for effects due to overlying skin and fat layers. 
FIG. 13 is an image of an embodiment of a near-infrared 
reflectance spectrometer system. 
FIG. 14 is a graph showing a set of uncorrected spectral 
10 
absorbance measurements from different human subjects. 
FIG. 15 is a graph showing a set of spectral absorbance 
measurements from different human subjects after applica-
tion of a PCA loading correction algorithm. 
15 	 FIG. 16 is a graph showing predicted pH versus measured 
pH for a PLS model of pH based on uncorrected spectral 
absorbance data. 
FIG. 17 is a graph showing predicted pH versus measured 
pH for a PLS model of pH based on spectra absorbance data 
20 corrected using a PCA loading correction method. 
FIG. 18 is a graph showing an aqueous absorption spec-
trum for the dye ADS780WS. 
FIG. 19 is a graph showing short distance absorption spec-
tra for a set of tissue-like phantom samples. 
25 	 FIG. 20 is a graph showing long distance absorption spec- 
tra for a set of tissue-like phantom samples. 
FIG. 21 is a graph showing long distance absorption spec-
tra for a set of tissue-like phantom samples after short-dis-
tance corrections have been applied. 
30 	 FIG. 22 is a graph showing uncorrected spectral absor- 
bance measurements from a set of tissue-like phantom 
samples. 
FIG. 23 is a graph showing spectral absorbance measure-
35 ments from a set of tissue-like phantom samples after short-
distance corrections have been applied. 
FIG. 24 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after SNV 
scaling corrections have been applied. 
40 	 FIG. 25 is a graph showing spectral absorbance measure- 
ments from a set of tissue-like phantom samples after PCA 
loading corrections have been applied. 
FIG. 26 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after short- 
45 distance corrections and SNV scaling corrections have been 
applied. 
FIG. 27 is a graph showing spectral absorbance measure-
ments from a set of tissue-like phantom samples after short-
distance corrections, SNV scaling corrections, and PCA load- 
50 ing corrections have been applied. 
FIG. 28 is a graph showing prediction results for a PLS 
model of dye concentration based on uncorrected spectral 
absorbance data. 
FIG. 29 is a graph showing prediction results for a PLS 
55 model of dye concentration based on spectral absorbance data 
corrected using three different correction methods. 
FIG. 30 is a graph showing spectral absorbance data 
recorded from different subjects at similar pH levels, and 
corrected using short-distance and SNV scaling correction 
60 methods. 
FIG. 31 is a graph showing the spectral absorbance data of 
FIG. 30, further corrected using PCA loading correction 
methods. 
FIG. 32 is a graph showing spectral absorbance data 
65 recorded from different subjects at different pH values and 
corrected using short-distance and SNV scaling correction 
methods. 
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FIG. 33 is a graph showing the spectral absorbance data of 	 overlying layer(s). Further, the new devices and techniques 
FIG. 32, further corrected using PCA loading correction 	 are aimed at reducing spectral interference from structural 
methods. 	 variations in tissues of interest that are not correlated to mea- 
Like reference symbols in the various drawings indicate 	 surements of a specific analyte within the tissues of interest. 
like elements. 	 5 Calibration equations developed based on spectra that are 
corrected for structural variations in tissues of interest, e.g., 
DETAILED DESCRIPTION 	 variations that affect the optical properties of tissues of inter- 
est, can be applied to different measurement regions on a 
General Methodology 	 single measurement subject, and/or to different measurement 
As described herein, a new fiber optic sensor and associ-  io subjects. For example, calibration equations developed based 
ated processor programmed and configured to perform cer- 	 on measurements performed on a patient's arm, which has a 
tain mathematical algorithms are used to extend the applica- 	 thin fat and skin layer, can be applied to spectra collected 
bility of NIRS for the noninvasive measurement of blood and 
	
from the patient's leg, which has a thicker fat and skin layer. 
tissue chemistry. The sensor is designed and used to remove 	 With a powerful light source and a sensitive detector, the 
the interfering spectral influence of one or more tissues that 15 devices and techniques described herein allow accurate spec- 
are not of interest, such as skin and fat, that overlay tissues of 	 tra to be collected from internal organs by reducing spectral 
interest and complicate measured signals from those tissues, 	 interference from overlying skin, fat, and muscle layers, and 
such as scattering from muscle tissue and/or from tissue of an 	 from structural variations in the internal organ tissues. 
organ in a patient, thus permitting greater generalization of 
	
Another advantage of the new approaches is the ability to 
chemometrics-based calibration equations. In particular, the 20 continually compensate for changing patient conditions such 
sensor has a detection port for detecting light scattered and 	 as variation in skin blood flow and surface texture. By remov- 
reflected from a patient and at least two illumination ports that 	 ing spectral interference from the overlying layers from the 
are located at different distances from the detection port. 	 spectra of the underlying layers, variations in the overlying 
Light from an illumination port that is close to the detection 	 layer spectra will cause little variation in the measured infor- 
port causes a reflectance spectrum that is due mainly to the 25 mation of the underlying layers obtained from the reflectance 
overlying fat and skin layers, while light from an illumination 	 spectra. By removing spectral interference from structural 
port that is more distant from the detection port causes a 	 variations in tissues of interest (e.g., the underlying layers), 
reflectance spectrum that is due to the combination of reflec- 	 variations in the structure of the tissues of interest will con- 
tions from the overlying skin and fat layers as well as deeper 	 tribute only relatively small variations to measured informa- 
muscle and/or organ layers. Information in the two spectra 30 tion for selected analytes in the tissues of interest. These 
and generalized chemometrics-based calibration equations 	 spectral interference corrections permit a more accurate 
can be used to extract chemical information about just the 	 determination of important blood and tissue chemistry 
tissue of interest, e.g., the underlying muscle and/or organ 	 parameters from patients. 
layer. 	 In-vivo calibration requires access to patients who have 
The sensor can also be used to reduce and/or remove inter-  35 variation in the analyte to be measured and offer the same or 
fering spectral influences that arises due to sample-to-sample 	 similar pathophysiology as expected in future application of 
structural variations in tissues of interest. For example, the 	 the devices and techniques. Often, it is difficult to obtain 
sensor can be used to measure a particular analyte in one or 	 access to a sufficient number of subjects and even when they 
more muscle tissue layers that underlie skin and fat layers. 	 are available, the variation may not be large enough to encom- 
After removing the spectral influence of the skin and fat 40 pass the entire pathophysiological range for the parameter 
layers from measured reflectance spectra, additional steps 	 that is sought to be modeled and measured. Another issue is 
can be performed by the sensor to remove spectral influences 	 how to incorporate the potential spectral interference from 
that arise from variations in optical properties of the muscle 	 new treatment methods. For instance, when developing meth- 
tissue. For example, optical properties of the muscle tissue 	 ods of measuring muscle pH to help guide resuscitation of a 
can vary according to a surface texture, and/or a capillary 45 patient from shock, it may be necessary to update the calibra- 
density and/or a fiber structure, and/or other structural prop- 	 tion equation used for determining muscle pH to account for 
erties of the muscle tissue. Variations in optical properties of 	 new therapeutic agents used when the patient is in shock. 
the tissues of interest typically affect an optical scattering 	 However, deliberately placing human test subjects in shock to 
coefficient of the tissue. 	 develop updated calibration equations is not possible. A supe- 
By generalizing the calibration equations based on cor-  5o rior method for developing robust calibration equations that 
rected reflectance spectra, the sensor can be used to perform 	 span large ranges of medical parameters and that can be 
accurate measurements when placed on muscle or other tis- 	 altered for new conditions and drugs would be to develop 
sue sites different from those used for calibration develop- 	 calibration equations on animals and transfer them directly to 
ment, and calibration equations developed from animal mod- 	 humans. By using animals it is possible, for instance, to 
els of pathophysiology can be applied to human subjects with 55 observe variations in analyte values caused by serious shock. 
clinically acceptable results. The methods can also be applied 
	
This can be done on multiple animals to validate the sensor 
during clinical measurement to continually correct for vary- 	 for this application before it is used on critically ill humans. 
ing patient conditions that will alter spectra, such as skin 	 Also some analytes are difficult to vary reliably in a clinical 
blood flow and surface changes which occur during wound 	 setting. However, the methods described herein will allow 
healing. 	 60 calibration equations developed on animals to be transferred 
The new devices and techniques described herein are 	 successfully for use on human subjects. Once the spectral 
aimed at reducing spectral interference from overlying tissue 	 influence of the overlying tissue layers are removed, the 
such as skin and fat on the spectra measured from underlying 	 muscle spectra of animals, such as swine, may be similar to 
muscle and/or organs. When successfully implemented, cali- 	 those of human subjects. Spectral differences in human and 
bration equations developed using these devices and tech-  65 animal muscle structure can be corrected using methods that 
niques can be applied to spectra acquired from almost any 	 remove these variations. Calibration equations derived from 
anatomical site, irrespective of the optical properties of the 	 swine muscle can then be used for human subjects. 
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Overall System 
As shown in FIG. 1, a portable, fiber-optic-based spectro-
scopic system 100 for measurement of reflectance spectra 
from a sample 102 located remotely from the system includes 
a lamp 104, a power supply for the lamp 106, an optical bench 5 
108, a shutter system 110, a driver for the shutter system 112, 
a spectrograph 114, a fiber optic cable 116, and a computer 
118. Light from the lamp is manipulated by optics within the 
optical bench 106 and can be controlled by a shutter system 
110 that is driven by a shutter driver 112. Light can be passed 10 
selectively by the shutter system 110 into a first fiber optic 
cable 116a or a second fiber optic cable 116d that guide the 
light to the sample 102 to illuminate the sample. 
When light is guided to the sample in the fiber optic cable 15 
116a or 116d, light is reflected from the sample 102 and 
collected by a third portion of the fiber optic cable 116c that 
guides the reflected light from the sample 102 to the spec-
trograph 114. The reflected light is analyzed by the spec-
trograph 114 to gather information about the sample 102. 20 
The spectrograph 114 can be a commercial portable spec-
trograph that can be operated by computer control. For 
example, an Ocean Optics USB2000 spectrograph with a 
grating optimized for performance in the wavelength range of 
500-1000 nm can be used. The spectrograph detector can be 25 
a 2048 element shallow-well linear CCD-array. The spec-
trograph can be equipped with a 200 micron wide slit to 
increase resolution, a collection lens to increase light collec-
tion efficiency at the detector, and a long pass filter to block 
light with a wavelength less than 475 mu from reaching the 30 
detector. The USB2000 spectrograph interfaces with the 
computer 118, e.g., through either a USB or RS232 port. 
The system 100 further includes an on-board computer 118 
for controlling the shutter driver 112, the spectrograph 114, 
and for processing, storing, and displaying data from the 35 
spectrograph. 
As shown in FIG. 2, optical bench 108 includes several 
primary optical components of the system. An illumination 
lamp 104 provides light to illuminate the sample. A first 
optical connector 212 couples the light to a first fiber-optic 40 
cable 116a for carrying light to illuminate the sample 102. A 
second optical connector 214 couples light to a second fiber-
optic cable 116d that carries light to illuminate the sample 
102. A shutter 250 can select whether of the first fiber-optic 
cable 116a or the second fiber optic cable 116d is illuminated 45 
by the lamp light. Optical bench 108 is used to set up and 
maintain proper alignment of the above-mentioned optical 
components to enhance the accuracy and reproducibility of 
the system 100 as a reflectance spectroscopy measurement 
system. Optical bench 108 can be fabricated from aluminum 50 
because aluminum can be easily machined to close tolerances 
and has high thermal conductivity to promote heat dissipation 
and minimize thermal stress and distortion on the compo-
nents of the system 100. 
Lamp 104 can be a white light source (e.g., a tungsten- 55 
halogen 9 W bulb such as a Welch-Allyn 8106-001 bulb) that 
is driven by a specially designed power supply 106 to allow 
for fast ramp-up and stable operation of the lamp. The lamp 
104 can be a continuous wave ("cw") light source or a pulsed 
light source. The lamp 104 is housed within its own machined 60 
reflector, so that it is relatively easy to replace when neces-
sary, and its optical alignment is assured through the design of 
the optical bench. The lamp rests against mechanical stops 
that ensure that it is accurately located with respect to the fiber 
optic cables 116a and 116d. Light from the lamp 104 can 65 
focused down a center axis of the optical bench 108 by a rear 
reflector 220 (e.g., an ellipsoidal reflector).  
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The general tamp configuration is illustrated in FIG. 3, 
which shows an incandescent light source 300 that includes 
an electrically resistive filament 302 within a transparent bulb 
304. Filament 302 is generally made of tungsten. Bulb 304 
can be made of glass, quartz, or other materials and can be 
evacuated or can be filled with a halogen gas, an inert gas, or 
a mixture of gases. Electrical current is supplied from a power 
supply 306 to the filament 302 through electrically conduc-
tive lead wires 308 that are electrically connected to a base 
310 of the light source. The electrical current causes the 
filament to radiate as a blackbody. The power supply 306 can 
supply direct current (DC) or alternating current (AC). To 
ensure stable operation of the lamp 104 and a constant spec-
trum emitted from the bulb, the filament is driven by an 
electrical circuit that supplies current to the filament such that 
the temperature of the filament remains substantially con-
stant, such that a stable blackbody radiation spectrum is emit-
ted from the bulb. 
Fiber Optic Cable System 
Referring again to FIG. 1, light from the light source 104 
can be used to excite an electromagnetic reflectance spectrum 
of the sample 102. Light can be ported from light source 104 
to the sample 102 in fiber optic cables 116a and/or 116d to 
illuminate the sample and to excite the sample optically. Light 
reflected from the sample 102 can be collected and delivered 
from the sample in a fiber optic cable 116c to a spectrograph 
114 that measures the reflectance spectrum of the sample 102. 
Illumination light in cable 116a exits the cable and is incident 
on sample 102 at a first distance (e.g., about 32 mm) from the 
entrance to the cable 116c that collects reflected light from the 
sample and guides the reflected light to the spectrograph 114 
for analysis. Illumination light in cable 116d exits the cable 
and is incident on sample 102 at a second distance (e.g., about 
2.5 mm) from the entrance to the cable 116c that is less than 
the first distance. Spectra from the sample that are collected 
when the sample is illuminated by light from cable 116a and 
from cable 116d can be used to extract detailed information 
about the sample, as explained below. 
Referring to FIG. 2, the fiber-optic illumination cable 116a 
for illuminating the sample 102 can be positioned directly in 
front of the lamp 104 with the end of the fiber-optic cable 
116a being at the focal point of the light emitted from the 
lamp 104. The cable 116a is inserted into position before 
system use, and a mechanical click stop ensures that the cable 
116a is properly positioned and secured in relation to the 
lamp 104 and the reflector 220. 
A second fiber optic cable 116d that also is used for illu-
minating the sample 102 is threaded into port 214 in the 
optical bench, e.g., at an angle to an optical axis of reflector 
220 of between about 5 degrees and about 90 degrees (e.g., 
between about 10 degrees and about 60 degrees, between 
about 15 degrees and about 35 degrees) with respect to the 
focused beam axis. Placing the cable 116d into port 214 at an 
angle to the focused beam axis results in a reduced intensity of 
light entering the cable 116d, compared to an on-axis position 
of cable 116d. However, because cable 116d delivers light to 
the sample at a closer distance to detection cable 116c than 
cable 116a does, the amount of light reflected by the sample 
and collected in detection cable 116c can be similar whether 
the sample is illuminated with the higher intensity light from 
cable 116a or the lower intensity light in cable 116d. 
As shown in FIG. 4A, the fiber optic cable can include 
different fiber bundles 116a, 116c, and 116d. The cable hold-
ing the sample bundles 116a or 116d can be contained in a 
common protective sheath with the cable holding the return 
bundle 116c outside the unit 100 housing the spectrograph 
114 and the light source 104. The sample bundles 116a, 116c, 
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and 116d can be gathered together outside the housing of the 
system 100, which contains spectrograph 114 and the lamp 
104, about 8-12 inches downstream from the housing. The 
cable containing the bundles 116a, 116c, and 116d connects 
spectrograph 114 and the lamp 104 to a probe head 400 that 
can be located at sample 102 to perform reflectance measure-
ments on sample 102. 
As shown in FIG. 413, at the sample end of the cable system, 
a probe head 400 includes illumination bundles 116a and 
116d, which are oriented perpendicular to a face of the hous-
ing 400 and perpendicular to a surface of sample 102. Hous-
ing 400 can hold the ends of fiber bundle 116a, illumination 
fiber bundle 116d, and detection fiber bundle 116c. Fiber 
bundle 116a can contain approximately 2666, 50 µm glass 
fibers with a numerical aperture (NA) of about 0.66. The 
detection bundle of fibers in return cable 116c returns 
reflected light from the sample to the spectrograph 114, and in 
one embodiment can contain 109, 50 µm glass fibers with a 
NA of about 0.66. At the sample end of the fibers, the fibers 
are oriented perpendicularly to sample 102. Along the length 
of the fiber optic cable, between light source 104 and spec-
trograph 114 at one end and the sample 102 at the other end, 
the sample illumination bundle 116a that delivers light to the 
sample is optically shielded from the return bundle 116c with 
an opaque material, such as an opaque tape or plastic sheath 
or tube, so that any light that leaks out of illumination bundles 
116a and/or 116d is not coupled into the return bundle 116c. 
To improve optical coupling between lamp 104 and sample 
fiber bundles 116a and 116d, a tapered NA converter can be 
placed at the end of sample cable bundles 116a and 116d to 
convert the 0.42 NA of the light source to the 0.66 NA of the 
fibers. This increases the collection efficiency into the fibers 
by about 15%. 
To reduce the NA of the return fiber bundle to 0.22 as may 
be needed to ensure proper interfacing with spectrograph 114, 
a 600 µm diameter fused silica rod can be placed at the end of 
fiber bundle 116c. To prevent stray light from entering the 
spectrograph 114, a black, light-absorbing epoxy or other 
material can be used to surround the silica rod. 
As shown in FIG. 5, light can be delivered from the unit 502 
housing the lamp 104 and the spectrograph 114 to the probe 
head 400 that delivers light to sample 102 in a fiber bundle 
116a and/or 116d, and light scattered from the sample can be 
collected and routed back to spectrograph 114 in fiber bundle 
116c. The bundles 116a, 116c, and 116d can be contained in 
a single cable that runs between housing unit 502 and probe 
head 400, and the cable can be several meters long to allow 
convenient access to and data collection from a sample or a 
patient. To minimize cross talk between not illumination 
bundles 116a and 116d and light detection bundle 116c, 
bundles 116a and 116d delivering illumination light from 
lamp 104 to sample 102 can be wrapped in black tape or other 
opaque material so that any leaked light does not couple into 
light return bundle 116c. 
As shown in FIG. 5, probe head 400 can have an illumina-
tion light port 506 for delivering light to the sample that is 
spatially separated by a distance (SD)2 from a detection light 
port 508 for receiving light from the sample. Fiber bundle 
116a can be coupled horizontally into probe head 400, and 
light from bundle 116a can be reflected from a 45 degree 
mirror 510 within the probe head and directed vertically 
towards sample 102 from light port 506. Similarly, light scat-
tered from sample 102 can be collected by light port 508 and 
reflected by a mirror 510 into detector fiber bundle 116c. 
Alternatively, fiber bundles 116a and 116c can enter probe 
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head 400 horizontally and then bend 90 degrees in a vertical 
direction such that they are directly coupled to light ports 506 
and 508, respectively. 
Illumination light port 506 can contain a 3.5 mm bundle of 
5 50 M glass fibers having an overall NA of 0.66 for directing 
light from housing unit 502 to sample 102. Sample 102 can 
include a top layer (e.g., a skin layer)102s, an overlying layer 
(e.g., a fat layer)102f, and an underlying layer (e.g., a muscle 
layer)102m, and light can be reflected from any or all of the 
io layers to the detector fiber bundle 116c. Detection light port 
508 that is coupled to bundle 116c is spaced a distance of 
between about 10 mm and about 100 mm (e.g., between about 
20 mm and about 50 mm, between about 30 mm and about 40 
mm, between about 30 mm and about 32 mm) from illumi- 
15 nation light port 506, anddirects diffusely reflected light from 
the sample to unit 502 housing spectrograph 114, where the 
reflected light can be analyzed. Light port 508 can have a 1 
mm diameter detection bundle of 50 µm glass fibers with a 
collective NA of 0.66. 
20 	 Probehead400 caninclude an additional illumination light 
port 514 configured similarly to first illumination light port 
506, but located closer to detection light port 508 than first 
illumination light port 506, at a distance (SD),. The distance 
(SD), can be between about 1 mm and about 5 mm (e.g., 
25 about 1.5 mm, about 2.5 mm, about 3 mm, about 4 mm). For 
example, the center of the 1 mm fiber bundle of second 
illumination light port 514 can be located about 2.5 mm from 
the center of the 1 mm diameter fiber bundle of detection light 
port 508, while the 3.5 mm diameter fiber bundle of first 
30 illumination light port 506 can be located about 30 mm from 
the center of detection light port 508. A diameter of light port 
514 can be smaller than a diameter of light port 506, so that, 
although more light is incident on sample 102 from the light 
port 506 than from light port 514, approximately the same 
35 reflected intensity is collected by detection light port 508 
regardless of whether the sample is illuminated with light 
from illumination port 506 or 514. Having similar intensities 
in the reflected spectra whether the sample is illuminated with 
light from illumination port 506 or 514 permits a good signal- 
40 to-noise ratio to be obtainedwithout having to integrate onthe 
detector for a longer time when light from one of the two 
illumination ports is used. 
The respective spacings between the two illumination light 
ports 506 and 514 and the detection light port 508 ((SD), and 
45 (SD) 2) are chosen in conjunction with the intensity and spec-
trum of the light emitted from illumination light ports 506 and 
514 and the reflectance spectrum of sample 102 to obtain 
particular information about sample 102. For example, spec-
troscopic system 100 can be used to direct near infrared 
5o radiation (e.g., radiation having a wavelength of 700-1000 
mu) through a human patient's skin to permit direct, nonin-
vasive measurement of blood chemistry or chemistry in tissue 
beneath the skin without removing a blood or tissue sample 
from the patient. In particular, system 100 can be used to 
55 measure muscle pH, muscle oxygen tension (P0 2), and blood 
hematocrit from continuous wave near infrared spectra 
obtained with the system. Shorter distance (SD), should be 
selected to property induce reflection only from tissue that is 
not of interest, such as skin and fat overlying a tissue of 
60 interest, such as muscle or tissue of an organ. As indicated 
below, this distance has been calculated for overlying skin 
and fat, where muscle is the tissue of interest. 
To record spectral information from a human patient, ther- 
mally conducting feet 520 of probe head 400 are placed in 
65 contact with a portion of the patient's body, light is directed 
from illumination ports 506 and/or 514 to the patient, and 
reflected light is collected in detection port 508. For example, 
US 8,873,035 B2 
15 
	
16 
feet 520 of probe head 400 can be placed in contact with the 	 that light from each of the sources illuminates a sample 
skin on the surface of a patient's forearm, so that light can be 	 directly. Light reflected by the sample is received by the 
emitted from illumination light ports 506 and/or 514, 	 system via detection port 584. 
reflected from tissue within a portion of the patient's body 	 Light sources 580 and 582 can each include an array of 
(e.g., the patient's hand, forearm, calf, thigh, stomach, or 5 light emitting diodes (LEDs). A number and spatial distribu- 
chest) and collected via detection light port 508. To record 	 tion of the LEDs can be selected to provide a particular 
information from the patient's muscle, light from illumina- 	 reflected light intensity in detection port 584 from each 
tion light ports 506 and/or 514 penetrates through skin layer 	 source. For example, light source 580 can include a relatively 
102s and fat layer 102f, which is generally between about 3 
	
densely packed array of LEDs, and light source 582 can 
mm and about 10 mm thick (e.g., between about 4 mm and io include a less densely packed array of LEDs, so that the 
about 5 mm thick), to reach muscle layer 102m, and then the 	 reflected light received in detection port 584 from each of the 
light is scattered from the muscle layer and collected in detec- 	 two sources is approximately equal in intensity. 
tion light port 508. In some embodiments, second illumina- 	 LEDs used in light sources 580 and/or 582 can provide 
tion light port 514 and detection light port 508 can be located 
	
light in varying regions of the electromagnetic spectrum. For 
together in one thermally conducting foot 520, e.g., in 15 example, LEDs can provide light having wavelengths in the 
embodiments involving detection of analytes in human 	 visible and/or ultraviolet and/or near-infrared and or infrared 
muscle. 	 regions of the spectrum. LEDs can also provide light in other 
Using lamp 104, e.g., an 8 Watt lamp, about 7 lumens of 	 regions of the spectrum, and in multiple regions of the spec- 
light can be emitted from a 3.5 mm diameter illumination 	 trum at the same time. In some embodiments, multiple dif- 
light port 506 or 514, or about 25 lumens of light can be 20 ferent types of LEDs having different light emission proper- 
emitted from a 6 mm diameter illumination light port. It has 	 ties (e.g., wavelength, intensity, and other properties) can be 
been determined empirically that a spacing of about 30 mm 	 provided in a single light source, such as light source 580 
between illumination light port 506 and detection light port 	 and/or light source 582. 
508 allows light collected in detection light port 508 to 	 In certain embodiments, light sources 580 and/or 582 can 
include a significant signal due to light scattered from muscle 25 include other types of sources (e.g., incandescent sources, 
tissue 102m underlying skin and fat layers 102s and 102f. 	 laser-based sources) integrated in probe head 400 or coupled 
When light is emitted from second illumination light port 514 	 to probe head 400. Detectors such as spectrometers can be 
that is positioned closer to detection light port 508 than first 	 incorporated into probe head 400, or can be optically coupled 
illumination light port 506, the light collected in detection 	 to probe head 400, e.g., using a fiber optic cable. 
light port 508 includes a significant signal from light scattered 30 	 Referring to FIGS. 6A and 613, the probe head 400 can be 
from the overlying skin and fat layers 102s and 102f. This 	 located in proper position by a light shield 600. Light shield 
second signal can be used to remove signal components that 	 600 has an opening 602 through which a foot 520 of probe 
arise due to scattering and/or absorption from the overlying 	 400 fits, an opening 604 though which illumination light port 
skin/fat layers 102s and 102f in the overall signal recorded 
	
506 fits, and an opening 606 through which a second foot 520 
when the patient's arm is illuminated with light from first 35 fits. The second foot can house illumination light port 514 fit 
illumination light port 506. Light emitted from the two illu- 	 and detection light port 508. Thus, the light shield locates the 
mination light ports 506 and 514 can originate from the same 	 feet 520 and the illumination and detection light ports 506, 
lamp 104, and shutter 250 can be used to control emission of 
	
514, and 508 of probe head 400 in a fixed position. Light 
light from each of first illumination light port 506 and second 	 shield 600 includes an opaque material that shields the 
illumination light port 514, as explained in more detail below. 40 patient's body from stray light, such that only light from 
Two signals corresponding to light scattering from shallow 	 illumination light ports 506 and/or 514 reaches the patient, 
skin/fat layers 102s and 102f and from deeper muscle layer 	 and such that light collected in detection light port 508 is due 
102m can also be obtained by using a single illumination light 	 only to light having a known spectrum that emerges from 
port and two light detection ports, one of which is located 
	
illumination light port 506. Light shield 600 can extend about 
closer to the illumination light port than the other. 	 45 3.5 cm in all directions from the detection light port 508 to 
Probe head 400 and its feet 520 can be made of a thermally- 	 shield the detection port from stray light. With probe head 400 
conductive material (e.g., aluminum or copper) to conduct 	 positioned in the light shield 600, the probe head can be 
heat away from a patient's skin. If the probe head is made of 	 positioned against the patient's body, for example, by taping, 
non-conductive material (e.g., plastic), heat delivered though 	 strapping, or sticking the light shield against the patient's 
illumination light ports 506 and/or 514 can be sufficient to 5o body. For example, probe head 400 can be held against light 
dilate blood vessels in the skin and alter skin blood volume of 	 shield 600 with double-sided adhesive, which allows probe 
the patient. This effect of heat on skin blood flow can change 	 head 400 to contact the patient's skin without excessive pres- 
a reflectance spectrum recorded from the patient. A thermal 	 sure that could alter the blood volume under the probe head. 
conductor in probe head 400 provides a thermal bridge 	 As shown in FIG. 6A, in some embodiments, the light 
between feet 520 at opposite ends of probe head 400, so that 55 shield can be made in one piece having a main part 601 that 
the temperature of a patient's tissue is substantially the same 	 has the various openings or apertures, and a cable manage- 
in the vicinity of the two illumination ports 506 and 514 and 	 ment part 603 connected to the main part 601 by a narrow 
detection port 508. 	 connecting region 605. In other embodiments, as shown in 
Referring to FIG. 513, in some embodiments, the light 	 FIG. 613, the light shield has a two-piece design in which the 
source can include one or more light-emitting diodes. Probe 60 cable management part 603 is separate from the main upper 
head 400 includes a first light source 580 positioned within 	 part 601. This arrangement enables the two parts to be sepa- 
probe head 400 to form an illumination port at a distance 	 rated by a distance greater than the length of connecting 
(SD) 2 from detection port 584. Probe head 400 also includes 	 region 605. In many of these embodiments, the light shield 
a second light source 582 positioned within probe head 400 to 	 cable management part 603 typically includes a clip 608 or 
form an illumination port at a distance (SD), from detection 65 other mechanism that can secure a cable that contains the fiber 
port 584. Light sources 580 and 582 do not include fiber optic 	 bundles 116a, 116c, and 116d that transport light between 
cables or other coupling elements, and are positioned such 	 spectrometer unit 502 and probe head 400. Clip 608 secures 
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the cable, so that the weight of the cable does not displace the 	 stored in the computer. It is possible for computer 118 to do 
probe head from its location on a patient. The shield 600 can 	 this independently for each channel of data acquisition. 
be made from plastic, for example, or from another light- 	 Parameters can be chosen to maximize a response in each of 
weight opaque material. The light shield can also be made 	 the reference channel and the sample channel without satu- 
from a thermally-conductive material, such as a thin sheet of 5 rating the detector. 
copper or aluminum to assist in the dissipation of excess heat, 	 Other Spectrometer Systems 
so that the heat is not transferred to the patient's skin. 	 Suitable light sources for spectrometer system 100 include 
Optical Bench and Shutter System 	 incandescent sources, e.g., lamps, light emitting diodes 
The optical bench can include a shutter system 110 for 	 (LEDs), laser-based sources, and other sources. For example, 
directing the light to different legs of the fiber optic cable io one or more LEDs can be combined to provide light for use in 
system. By controlling the path of the light in the cable 	 making reflectance measurements from a sample. The light 
system, the shutter system can be used to selectively illumi- 	 provided by the various light sources can include wavelengths 
nate the sample with different illumination fibers 116a or 	 in selected regions of the electromagnetic spectrum such as 
116d. 	 the infrared and/or near-infrared region, the visible region, 
Referring again to FIG. 2, optical bench 108 provides a 15 the ultraviolet region, and/or other regions of the electromag-
mount for a stepper-motor 240 that actuates optical shutter 	 netic spectrum, for example. 
250 of the shutter system 110. Shutter 250 is positioned 
	
In some embodiments, spectrometer system 100 may be 
between lamp 104 and two fiber optic cables 116a and 116d, 	 configured to illuminate a sample directly, without coupling 
and is shaped such that it can either block or pass light to each 
	
illumination light from a light source through a fiber optic 
of the two fiber optic cables. In FIG. 2, only the top edge of the 20 cable. For example, the light source can be an incandescent 
shutter 250 is shown. A profile of opaque shutter 250 is shown 	 lamp positioned to directly illuminate a sample through an 
in FIG. 7. Shutter 250 is coupled to stepper motor 240 by a 	 illumination port such as an aperture. Light reflected from the 
shaft that passes through a hole 710 in the shutter. When the 	 sample can then be received by one or more detectors and 
shaft rotates, the shutter is rotated about an axis passing 	 analyzed. 
through the center of the hole 710. A second shaft (not shown) 25 	 In certain embodiments, more than one detector can be 
fixed to the optical bench 108 passes through a second hole 	 used. For example, light can be used to illuminate a sample 
720 in shutter 250 and limits the rotational motion of shutter 	 from an illumination port, and illumination light reflected 
250. 	 from the sample can be received in two detection ports. Each 
When shutter 250 is rotated maximally in the clockwise 	 of the two detection ports can be coupled to a spectrometer 
direction, as shownin FIG. 7, hole 730 in the shutteris located 30 configured to measure a spectrum of the reflected light, so that 
between lamp 104 and fiber optic cable 116a that leads to 	 the detection system includes two spectrometers operating in 
sample 102, so that light propagates through hole 730 and 	 parallel. Spectral data can be acquired simultaneously at each 
sample 102 is illuminated by light emerging from fiber bundle 	 detection port, which can provide a speed advantage relative 
116a. With shutter 250 in this position, light reflected from 	 to systems that have only a single spectrometer. The system 
sample 102 is collected by cable 116c and guided to spec-  35 can operate without use of a shutter system for blocking and 
trograph 114. In this position, end 740 of shutter 250 blocks 	 unblocking illumination ports, which can reduce the cost of 
light from entering cable 116d. 	 the system and increase the system's mechanical reliability. 
When shutter 250 is rotated counterclockwise to a middle 	 Spectral Correction Algorithms 
position, such that the shaft passing through hole 720 is 	 There are three different correction algorithms that can be 
positioned in the middle of hole 720, hole 730 is rotated out of 40 implemented. Although each correction algorithm works 
the beam path of the light emitted from lamp 104. Thus, light 	 well individually, any two algorithms, or all three algorithms, 
does not pass through hole 730, and is blocked by opaque 	 can be used together to correct measured spectral data. 
shutter 250 from entering the sample cable 116a. Light is also 	 1. Short-Distance Corrections 
blocked from entering the fiber bundle 116d by end 740 of 
	
Spectral contributions that arise from tissue layers overly- 
shutter 250. 	 45 ing tissue layers of interest (e.g., underlying tissues) can be 
When shutter 250 is rotated maximally in the counter- 	 corrected by subtracting the contributions due to the overly- 
clockwise direction, light does not pass through hole 720 and 
	
ing layers from reflectance spectra that include contributions 
is blocked by the opaque shutter from entering sample cable 	 from both the overlying and underlying layers. Reflectance 
116a. Light passes over angled edge 750 of shutter 250 and 	 spectra that include contributions from both types of layers, 
enters fiberbundle 116d and reaches spectrograph 114. In this 5o and reflectance spectra that include contributions from sub- 
position, spectrograph 114 measures a reflectance spectrum 	 stantially only overlying layers, can be measured separately 
of sample 102 when the sample is illuminated by fiber bundle 	 using spectrometer system 100. For example, as shown in 
116d. 	 FIG. 5, the distance (SD)2 between illumination port 506 and 
Computer 118 controls shutter 250 to switch data acquisi- 	 detection light port 508 is greater than the distance (SD), 
tion in spectrograph 114 between collecting data in a first 55 between illumination port 514 and detection light port 508. 
channel (i.e., when sample 102 is illuminated with light from 	 The distance (SD) 2 can be selected such that reflectance spec- 
fiber bundle 116a) and collecting data in a second channel 	 tra R f_ recorded when sample 102 is illuminated with light 
(i.e., when sample 102 is illuminated with light from fiber 	 from illumination port 506 contain spectral information about 
bundle 116d). Computer 118 can control shutter 250 via a 	 skin layer 102s, fat layer 102f, and muscle layer 102m. The 
shutter driver circuit. One embodiment of a suitable shutter 6o distance (SD), can be selected such that reflectance spectra, 
driver circuit is shown in FIG. 8. The operation of this circuit 	 R,, recorded when sample 102 is illuminated with light from 
is described in U.S. Pat. No. 7,245,373, the entire contents of 
	
illumination port 514, substantially contain spectral informa- 
which are incorporated herein by reference. 	 tion only about skin layer 102s and fat layer 102f. The instru- 
Computer 118 also controls how spectrograph 114 collects 	 ment parameters, fiber size, and spectrometer integration 
data. For example, computer 118 can control an integration 65 time of system 100 can be chosen to obtain a high signal-to- 
time of the spectrograph detector, a number of spectra to be 	 noise ratio in the reflectance spectra for the dynamic range of 
averaged, and an amount of smoothing before spectra are 	 the system for each illumination port and detection port. 
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Before subtracting out spectral information contained in 
the R f spectra that is due to overlying layers from the spec-
trum R f- that includes information about both the overlying 
and underlying tissue layers, the R f spectra  can be normal-
ized to the R f_ spectra, so that the spectra share a common 
measurement space. To transform R f into  the measurement 
space of R f_, a photometric mapping of the R f spectra  to the 
Rf_ spectra is performed. First, reflectance spectra are 
recorded from three or more optically homogenous reflec-
tance standards having reflectivity values ranging from 2% to 
99% when light is incident on sample 102 from illumination 
port 506 and from illumination port 514. Next, the reflectance 
spectrum for each reference standard is estimated by dividing 
each measured intensity spectrum by the spectrum recorded 
for the 99% reference standard. For example, the estimated 
reflectance, R, of the 50% standard is 50/99 (i.e., 50.5%). 
Likewise, the estimated reflectance of the 99% standard is 
99/99 (i.e., 100%). Finally, a wavelength-specific polynomial 
model correlating spectra, R f, recorded when the standard is 
illuminated with light from second light port 514 with spec-
tra, R f_, recorded when the standard is illuminated with light 
from first light port 506. Each wavelength-specific model is 
used to adjust the scale of the reflectance estimates from R fto 
Rf_. This procedure corrects for differences in light through-
put and collection efficiency when the different illumination 
ports 506 and 514 are used. The polynomial model can be 
implemented as follows: 
R f„ (n,k)=aR f(n,k)2+bR f(n,k)+c 	 (1) 
where n and X are indices representing the target reflectance 
values (2-99%) and the light wavelength, respectively, and a, 
b, and c are wavelength-specific polynomial coefficients. The 
polynomial coefficients allow a mapping of future measure-
ments of tissue spectra, R,,, to spectra, R,,, that are normal-
ized to the R f_ spectra. Equation 1 describes a second order 
polynomial model. In general, however, polynomial models 
of higher order (e.g., third order, fourth order, and even higher 
order) can be implemented. 
After normalization of the spectra recorded with light from 
the two different illumination light ports 506 and 514, the 
spectra recorded with the different illumination light loca-
tions are orthogonalized (i.e., the spectral components due to 
the overlying layers are removed from the spectra that include 
components that are due to both the overlying and underlying 
layers. Orthogonalization involves matrix multiplication. 
First, a wavelength dependent weight, w, indicative of a cor-
relation between the spectra R f and  R f- is determined from 
the following equation: 
w=R f „ 7R f(R f R f)- 1 	 (2) 
where the superscript T indicates the transpose of a matrix, 
and R f is  a vector that corresponds to a spectrum of reflected 
light recorded when light is incident on sample 102 from 
illumination port 514 and then photometrically mapped onto 
the measurement space of R f_. After the weight is deter-
mined, the spectral features of the overlying layers can be 
removed by using the following equation: 
Corr R f  -R Jv 7 	 (3) 
where ko,,, is an orthogonalized spectrum that results after the 
reflectance components due to skin and fat are removed, and 
that substantially includes only information from the under-
lying (muscle) layer 102m. k o ,,t can beused with PLS or other 
multivariate calibration techniques to develop calibration 
equations for determining chemical properties of the under-
lying layer 102m from the orthogonalized reflectance spec- 
20 
trum, Ro ,,t, where the calibration equations are independent of 
the optical effects of overlying layers. 
When the calibration equations are used in a medical moni-
toring device, patient spectra can be collected with a fiber 
5 optic probe of the same design as used to generate the cali-
bration equations, and the orthogonalized spectrum should be 
calculated before it is used in the calibration equation. 
2. Correction by Standard Normal Variate Scaling 
Standard normal variate (SNV) scaling techniques can be 
io used to reduce scatter and other undesired contributions to 
measured reflectance spectra. Suitable SNV implementations 
are disclosed, for example, in R. J. Barnes et al., Applied 
Spectroscopy 43, 772 (1989), the entire contents of which are 
incorporated herein by reference. SNV methods can be used, 
15 for example, to reduce contributions to measured reflectance 
spectra that arise from variations in optical properties of 
tissues of interest, such as muscle tissues. 
3. Correction by Principal Component Analysis Loading 
In some embodiments, spectral reflectance measurements 
20 are recorded from multiple locations on a subject's body, 
and/or from multiple subjects. Variations in optical properties 
of tissues of interest from one subject to another, for example, 
can introduce variations into the reflectance data that are 
unrelated to measurement analytes of interest. For example, 
25 in muscle tissue reflectance spectra recorded from a set of 
subjects, a measurement analyte of interest may be muscle 
tissue pH. However, in addition to variations that arise due to 
changes in muscle tissue pH, reflectance spectra recorded 
from muscle tissues in different subjects can also include 
30 spectral contributions that arise from variations in muscle 
tissue texture, and/or capillary density, and/or fiber structure, 
and/or other structural properties of the muscle tissues in the 
different subjects. These variations in structural properties 
typically produce variations in wavelength-dependent scat- 
35 tering coefficients for the muscle tissues in the different sub-
jects. 
A large set of subjects may be used to model optical prop-
erty variations in tissues of interest. However, the time and 
expense associated with measuring and analyzing reflectance 
40 spectra from a large set of test subjects may make this 
approach impractical for clinical applications. Alternatively, 
numerical algorithms can be used to reduce and/or remove 
spectral contributions in reflectance spectra that arise from 
optical property variations in tissues of interest, prior to using 
45 the reflectance spectral data in PLS modeling applications to 
measure analytes of interest. 
Principal component analysis (PCA) loading corrections 
can be used to reduce and/or remove contributions to reflec-
tance spectra that arise from analyte-irrelevant variations in 
50 optical properties of tissues of interest (e.g., tissues in which 
analytes of interest are measured). Optical properties that 
exhibit such variations can include scattering properties, 
absorption properties, tissue refractive indices, and other 
properties. In general, variations in infrared absorption by 
55 tissues of interest are also related to concentrations of one or 
more analytes of interest. Accurate measurement of analytes 
of interest may therefore include determining and correcting 
for the analyte-irrelevant contributions to reflectance spectra. 
PCA analysis can be used to obtain spectral "signatures" of 
60 the analyte-irrelevant variations, which can then be removed 
from the spectral reflectance data via orthogonalization steps. 
PCA loading corrections can be applied during both calibra-
tion and predictive steps to further improve PLS models con-
structed from the corrected spectral reflectance data. 
65 Variations in spectral reflectance measurements that arise 
from variations in optical properties of tissues of interest can 
be reduced and/or removed in a series of steps. For example, 
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in some embodiments, a first analysis step includes determin-
ing variations in spectral reflectance data that are not relevant 
to a target analyte by PCA on a set of spectra collected from 
different subjects (and/or from different locations on the same 
subject) in the same calibration set with substantially similar 
values of the analyte. The variations can be expressed as a set 
of loading vectors of principal spectral components obtained 
from PCA. The first analysis step is described by Equation 4: 
X,,,,,X,X,,__,-SP 7+E 	 (4) 
In Equation 4, X o is a matrix with dimensions mo xn. Each of 
the mo rows of Xo corresponds to a reflectance spectrum 
recorded for a different sample used for PCA, and n is the 
number of wavelength points in each reflectance spectrum. 
The spectra in X o include analyte-irrelevant spectral reflec-
tance variations. Matrix X......  has dimensions mo xn and 
includes mo rows, where each row is a Ixn vector whose 
elements correspond to the column mean values of X o, so that 
subtracting X o,mean from Xo yields matrix Xo,m,  with dimen-
sions mo xn, where Xo,m,  is a mean-centered matrix of X 0 . S is 
a PCA score matrix with dimensions m o xfo, where to is a 
number of principal components used to model variations in 
Xo . Matrix P is the PCA loadings matrix and has dimensions 
nxfo . Matrix E, with dimensions mo xn, is a matrix of spectral 
residuals of X o that are not modeled by PCA. 
In a second analysis step, spectra used for PLS calibration 
and spectra used for PLS -based prediction are orthogonalized 
with respect to the loading vectors of the principal compo-
nents obtained in the first step. Spectral contributions due to 
variations in optical properties of the tissues of interest are 
reduced and/or removed in the corrected spectra which result 
from the second analysis step. The second analysis step is 
described by Equation 5: 
X rr(X XO,__ (m,,,)) — (X Xo__ (_,))P.P. T+ 
Xo,__,(_") =X— (X—XO,__,(_"))P1P1 T ( 5) 
In Equation 5, X.,,t is the orthogonalized (e.g., corrected) 
spectral matrix with dimensions mxn, where m is the number 
of samples, e.g., the m rows of X o ,,t correspond to corrected 
reflectance spectra recorded from m different samples. 
Matrix X with dimensions mxn corresponds to m original, 
uncorrected spectra. Matrix X o , mea„ (m ,,,) with dimensions 
mxn includes m rows, where each row is a 1 xn vector whose 
elements correspond to the column mean values of X o . Pi , 
with dimensions nxfi , is a truncated loadings matrix, where 
the number of columns fi is equal to a number of orthogonal-
ization factors used in the orthogonalization procedure. In 
general, fi is less than or equal to t o, and a value for f, is 
selected on the basis of the element values in the S and P 
matrices calculated in Equation 4. Following orthogonaliza-
tion, the corrected reflectance spectra in matrix X.,, t can be 
used in PLS calibration and/or modeling to predict values of 
analytes of interest. 
4. Combined Correction Methods 
In certain embodiments, any two or all three of the short-
distance methods, SNV methods, and PCA loading methods 
can be combined to correct reflectance spectra by removing 
spectral features that do not arise from measurement analytes 
of interest. For example, in some embodiments, short-dis-
tance correction methods can be applied first to a set of 
reflectance measurements to correct for spectral features due 
to tissue layers that overlie tissue layers of interest. SNV and 
PCA loading corrections can then be applied to the short-
distance-corrected spectra in succession to correct for varia-
tions in optical properties in the tissue layers of interest, e.g., 
where the set of reflectance measurements includes reflec-
tance data measured at different locations on a subject's body, 
and/or reflectance data from different subjects. 
22 
In general, the algorithms disclosed herein can be applied 
in a desired order to correct spectral reflectance data. The 
suitability of one or more correction algorithms applied in a 
selected order to reflectance data is typically assessed by 
5 determining the accuracy of a PLS model for an analyte of 
interest that is developed based on the corrected spectral 
reflectance data (discussed in more detail in the Examples). 
Implementation 
The equations and algorithms described above can be eas- 
io ily implemented in hardware or in software, or in a combina-
tion of both. The invention can be implemented in computer 
programs using standard programming techniques following 
the method steps and figures disclosed herein. The programs 
can be designed to execute on programmable processors or 
15 computers, e.g., microcomputers, each including at least one 
processor, at least one data storage system (including volatile 
and non-volatile memory and/or storage elements), at least 
one input device, such as a keyboard or push button array, and 
at least one output device, such as a CRT, LCD, or printer. 
20 Program code is applied to input data to perform the functions 
described herein. The output information is applied to one or 
more output devices such as a printer, or a CRT or other 
monitor, or a web page on a computer monitor with access to 
a website, e.g., for remote monitoring. 
25 Each program used in the new system is preferably imple-
mented in a high level procedural or object oriented program-
ming language to communicate with a computer system. 
However, the programs can be implemented in assembly or 
machine language, if desired. In any case, the language can be 
30 a compiled or interpreted language. 
Each such computer program can be stored on a storage 
medium or device (e.g., ROM or magnetic diskette) readable 
by a general or special purpose programmable computer, for 
configuring and operating the computer when the storage 
35 medium or device is read by the computer to perform the 
procedures described herein. The system can also be consid-
ered to be implemented as a computer-readable storage 
medium, configured with a computer program, where the 
storage medium so configured causes a processor in the com- 
40 puter to operate in a specific and predefined manner to per-
form the functions described herein. 
Although any communications network can be used to 
obtain results from remote monitoring, the Internet or wire-
less systems provide useful choices to transmit data. 
45 
EXAMPLES 
Spectral Effects of Short-Distance Corrections 
50 	 Example 1 
Experiments were performed to determine an optimum 
distance (SD), between the illumination probe 514 and detec- 
tion probe 508 to correct for the presence of skin and fat over 
55 human muscle in an embodiment of system 100. A probe 400 
with an adjustable short source-detector distance, (SD) l , of 2 
mm-6 mm and a fixed long source-detector distance, (SD) 21  
of 32.5 mm was used to measure spectra from four different 
anatomical positions (arm, calf, shoulder, and thigh) having 
6o different fat layer thicknesses on four different subjects to 
determine which (SD), distance would result in the lowest 
variation in measurements of an analyte for measurements 
performed on the different locations of the person. Ideally, the 
spectral differences caused by the different fat thicknesses 
65 from the different positions on a person should be corrected 
after the orthogonalization, i.e., all four spectra measured 
from different body parts of a person should overlap, because 
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the same information should be recovered from a person's 
muscles regardless of what body part is measured. Moreover, 
the spectral difference caused by the skin color and different 
fat thickness on different people should be decreased, i.e., a 
better correlation between the spectra and the hematocrit 
("Hct") values of patients should be obtained when the spec-
tra are orthogonalized to remove spectral contributions from 
the overlying skin and fat layers. 
Reflectance spectra were measured from the arm, calf, 
shoulder and thigh of four human subjects using a fixed (SD)2 
distance of 32.5 mm and five different (SD), distances of 1.83 
mm, 2.5 mm, 3.0 mm, 4.0 mm, and 5.4 mm. The actual fat 
thicknesses for the subjects were measured at different posi-
tions using ultrasound and are listed in Table 1 below. The 
thigh position chosen for this study was on top of the rectus 
femoris muscle (front thigh), where thicker fat was found 
than the position on top of the vastus lateralis muscle (side 
thigh). Each person's Hct level was measured via invasive 
blood testing, and the levels are listed in Table 2 below. 
TABLE 1 
Arm (mm) 	 Calf (mm) Shoulder (mm) Thigh (mm) 
SubjectA 4.4 3.5 9.8 9.5 
Subject  1.8 5.8 9.0 10.7 
Subject  3.2 1.4 2.6 2.0 
Subject  6.3 9.5 11.6 18.6 
TABLE 2 
SubjectA 41.5% 
Subject B 44.8 
Subject 43.4% 
Subject 40.8% 
FIGS. 9A-9E show the effects of short-distance corrections 
for overlying tissue layers on the spectra recorded from a 
SubjectA for different (SD), distances. The results in FIGS. 
9A, 913, 9C, 9D, and 9E were obtained for (SD), distances of 
1.83 mm, 2.5 mm, 3.0 mm, 4.0 mm, and 5.4 mm, respectively. 
In each figure, spectra 810 are R f_ spectra obtained when 
different parts of the subject's body were illuminated with 
light from illumination port 506, spectra 820 are R f spectra 
obtained when different parts of the subject's body were 
illuminated with light from illumination port 514, and spectra 
830 are orthogonalized spectra. 
Differences among spectra recorded at different positions 
on a subject's body appear generally as baseline shifts caused 
by the different fat thicknesses, and are decreased by the 
orthogonalization process. Corrected spectra 830 are closer 
together than raw spectra 810. For probes having (SD), dis-
tances of 1.83 mm, 2.5 mm, and 3.0 mm, the orthogonalized 
spectra are closer together and their shapes are unchanged 
compared to the raw spectra. For probes having (SD), dis-
tances of 4.0 mm and 5.4 mm, the spectra are closer together 
after correction, and certain features of the spectra are 
changed. For example, the absorption peak due to hemoglo-
bin (Hb) at 760 nm is less pronounced after orthogonalization 
at (SD), distances of 4.0 mm and 5.4 mm. This may imply that 
certain useful information from the muscle layer (where sig-
nificant Hb absorption occurs) is diminished by the correction 
process. This is contrary to the objective of correcting for the 
influence of fat and skin layers, but keeping the muscle infor-
mation. This effect may be due to deeper light penetration at 
large (SD), distances. As light penetrates more deeply inside 
tissue, more information about the muscle layer is captured, 
24 
and the correction between the short (SD), distance and the 
long (SD)2 distance may sacrifice some muscle information. 
Similarly, FIGS. 1OA-10E show correction results for 
spectra from the four body parts of a Subject C for different 
5 (SD), distances. While Subject A had Caucasian skin and 
Subject C had Negroid skin, the results of the orthogonaliza-
tion process are similar for both subjects. Absolute absor-
bance values of Subject A's and Subject C's skin are quite 
different, as evidenced by a comparison of spectra 820 in 
10 FIGS. 9A-9E with the spectra 820 in FIGS. 10A-10E. How-
ever, the corrected spectra for the two subjects, for which the 
spectral components due to the skin are subtracted out, are 
quite similar. 
To examine correlations between corrected spectral reflec- 
15 tance data and Hct values, mean absorbance values of the 
spectra at the arm, calf, shoulder, and thigh of a subject were 
calculated for each subject, and a relationship between the 
subject's mean absorbance value and the corresponding sub-
ject Hct value was established for each (SD), distance before 
20 and after short-distance corrections were applied to the 
reflectance spectra. A predominant hemoglobin feature in 
tissue absorption spectra is the deoxyhemoglobin peak at 760 
mu, and the height of this peak in the spectra for each subject 
should be linearly related to the hematocrit level of the sub- 
25 ject. 
Table 3 shows the R 2 correlation values of the relationship 
between the mean absorbance at 760 mu for 4 different ana-
tomical positions and the Hct values for the four different 
(SD), distances (i.e., 1.83 mm, 2.5 mm, 3.0 mm, and 4.0mm). 
30 From the values in Table 3, it can be seen that R 2 improved 
after the correction. This indicates that a strong correlation 
between the spectra and the Hct values is established by 
correcting the (SD)2 distance spectra, R f_, against the (SD), 
distance spectra, R,,. 
35 
TABLE 3 
(SD), Distance 	 Before 	 After 
1.83 mm 	 0.577 	 0.967 
40 	 2.5 mm 	 0.480 	 0.996 
3.0 mm 	 0.471 	 0.975 
4.0 mm 	 0.476 	 0.925 
From the above results, an (SD), distance of about 2.5 mm 
45 may provide optimal results for this embodiment. In general, 
the short source-detector distance can be determined through 
experiments as described above, or through Monte Carlo 
modeling, if the absorption and scattering coefficients of all 
the sample layers are known. 
50 
Example 2 
Another example of short-distance correction of reflec-
tance spectra to improve correlations between measured 
55 spectral intensities and analytes of interest is shown in FIGS. 
11 and 12. FIG. 11 shows a series of measurements of maxi-
mum heme absorption (including contributions from both 
hemoglobin and myoglobin) in 17 different human subjects. 
The spectral data from each subject was collected from the 
60 flexor digitorum profundus. The spectral data in FIG. 11 is 
uncorrected, and there is no strong correlation between maxi-
mum heme absorbance and blood hematocrit levels measured 
for each of the subjects. 
FIG. 12 shows maximum heme absorbance versus blood 
65 hematocrit calculated from reflectance spectra after short- 
distance corrections were applied to the reflectance spectra to 
correct for overlying skin and fat layers in the 17 subjects. A 
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stronger linear relationship is observed in the corrected data, 
suggesting that predictive models such as PLS models based 
on the corrected spectral data will more accurately estimate 
hematocrit levels in patients and other subjects. 
5 
Spectral Effects of PCA Loading Corrections 
Example 3 
To evaluate the effects of PCA loading corrections on mea- io 
sured spectral reflectance data, a set of reflectance spectra 
were collected from human subjects performing a handgrip 
exercise, and multi-subject venous blood pH models were 
developed and evaluated based on the reflectance measure-
ments. The handgrip exercise protocol included a 2 second 15 
contraction of a subject's hand, followed by a 1 secondrelax-
ation, at four different effort levels: 15% maximum voluntary 
contraction (MVC), 30% MVC, 45% MVC, and 60% MVC. 
As exercise intensity increases, pH falls to a lower level at the 
end of each exercise bout. Each bout was 5 minutes in length, 20 
and bouts were conducted 40 minutes apart. Bloodwas drawn 
from a venous catheter placed in a vein close to the measure-
ment muscle. Samples were obtained just prior to each bout 
(to provide a baseline pH measurement), every minute during 
the exercise bout, and at 5, 10, and 20 minutes post-exercise. 25 
Blood samples were measured using an I-Stat CG4+ cartridge 
(available from i-STAT, East Windsor, N.7.) to determine 
venous pH. Spectral reflectance measurements were made 
using an embodiment of spectrometer system 100 similar to 
the embodiment shown in FIG. 13. 30 
Spectral reflectance data was measured from six different 
subjects. Accuracy of PLS-based pH prediction models was 
estimated before and after PCA loading correction of the 
spectral reflectance data using a "leave-one-subject-out" 
cross validation procedure. In this procedure, pH determina- 35 
tions for each subject are made based on a calibration equa-
tion developed from data measured for the other 5 subjects. 
Accuracy is estimated by calculating a root mean square error 
of prediction (RMSEP) between pH values obtained from 
NIRS reflectance measurements and from venous blood 40 
analysis. 
FIG. 14 shows a set of calibration spectra from different 
subjects at a single pH value (about 7.35) before PCA loading 
corrections were applied. FIG. 15 shows the same set of 
calibration spectra after PCA loading corrections were 45 
applied. Following application of the correction procedure, 
the spectra at the same pH are nearly coincident. This is 
consistent with a reduction of subject-to-subject variations in 
the measured reflectance data which are not related to the 
analyte of interest, e.g., muscle pH. 50 
Calibration equations were developed using PLS from 
reflectance spectra and blood samples collected during the 
handgrip exercise bouts. Blood pH values were interpolated 
at time intervals corresponding to measured spectral data, 
where appropriate. FIG. 16 shows results of measured pH (for 55 
venous blood) versus predicted pH (from NIRS measure-
ments) for uncorrected reflectance spectra, with calibration 
according to leave-one-subject-out cross-validation. The 
diagonal line in the figure indicates a perfect match between 
measured and predicted pH values. Predictions of pH based 60 
on uncorrected spectra have an average correlation, measured 
by coefficient of determination R 2, of about 0.44, indicating 
that a correspondence between measured and estimated pH 
values is not strong. 
FIG. 17 shows results of measured pH versus predicted pH 65 
based on reflectance spectra that were corrected using PCA 
loading correction methods. The R 2 for the correspondence  
26 
between measured and predicted pH values based on the 
corrected spectra is about 0.64 and the predicted pH values 
are more closely clustered along the diagonal line, indicating 
that the pH model based on the corrected spectra is signifi-
cantly more accurate than the model of FIG. 16. The RMSEP 
is 0.025 pH units, which describes the observed scatter 
around the diagonal line. 
Spectral Effects of Combined Correction Algorithms 
Example 4 
To evaluate the effects of combining multiple spectral cor-
rection algorithms, three-layer (e.g., skin, fat, and muscle) 
tissue-like solidphantoms were prepared. Agar (AgarA7049, 
available from Sigma-Aldrich Inc., St. Louis, Mo.) was used 
as a solid base material for the phantoms. Intralipid (available 
from Baxter Healthcare Corp., Deerfield, Ill.) was used as a 
scattering layer. Fabrication followed a procedure similar, for 
example, to the procedure described in R. Cubeddu et al., 
Physics in Medicine and Biology 42, 1971 (1997), the entire 
contents of which are incorporated herein by reference, 
except that different absorbers were used. Each layer was 
fabricated separately, and then skin and fat layers were placed 
on top of the muscle layer. 
Each phantom included a 1.0 mm thick skin layer with 0.15 
mg/mL melanin (Melanin M8631, available from Sigma-
Aldrich Inc., St. Louis, Mo.) as an absorber. Absorbers in the 
muscle layer were a 2.2% solution of 6x10 -4 mL/mL India 
ink (available from Scientific Device Lab Inc., Des Plaines, 
Ill.) and NIR dyeADS780WS (available from American Dye 
Source, Inc., Quebec, Canada) of varied concentrations. 
The concentration of the India ink was selected based on 
the concentration of blood in tissue, which is approximately 
2.2%. The NIR dye has an absorption maximum at a wave-
length of about 780 mu, similar to deoxygenated hemoglobin, 
while India ink has relatively wavelength-independent 
absorption properties. No absorber was introduced into the fat 
layer since human fat typically has a very low absorption 
coefficient. Reduced scattering coefficients (µ ') for skin and 
fat were 1.5 mm- ' and 1.2 mm- ', respectively. Tissue phan-
toms were prepared so that each phantom had a muscle-
reduced scattering coefficient (µ ') of 0.5 mm - ', 0.65 mm i , 
or 0.8 min i , a fat thickness of 2.0 mm, 4.0 mm, or 6.0 mm, 
and a muscle dye concentration of: 6.67 µg/mL, 9.08 µg/mL, 
13.31 µg/mL, 15.76 µg/mL, 17.92 µg/mL, 20.22 µg/mL, 
22.58 µg/mL, 24.82 µg/mL, or 26.68 µg/mL. Sets of tissue 
phantoms having one of the foregoing muscle dye concentra-
tion were fabricated so that each member of the set had one of 
the 3 different levels of fat thickness and one of the 3 different 
muscle scattering coefficients, e.g., nine different phantoms 
were prepared with the same muscle dye concentration. The 
phantoms were fabricated in three groups of 27 phantoms 
with low, medium or high muscle dye concentrations, over a 
period of 3 days. Samples were sealed with plastic to avoid 
water loss, covered with aluminum foil to avoid photo-
bleaching, and stored in a refrigerator to be measured in 
random order the day after fabrication. 
Reflectance spectra of each of the phantoms at 2.5 mm and 
30 mm source-detector (SD) separations were measured 
using system 100. An 8.5 W tungsten lamp (model 7106-003, 
available from Welch-Allyn Corp., Skaneateles, N.Y.) was 
used for illumination of the phantoms, and a spectrometer 
(USB2000, available from Ocean Optics Inc., Dunedin, Fla.) 
was used to collect spectral reflectance data. The two-dis-
tance probe of system 100 had one detector fiber bundle and 
two source fiber bundles 30 mm (long distance) and 2.5 mm 
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(short distance) away from the detector bundle. A diameter of 
the detector fiber bundle was 1.0 mm, and diameters of the 
source fiber bundles at the long distance and at the short 
distance were 3.5 mm and 1.0 mm, respectively. During col-
lection of reflectance spectra, the detector bundle was con-
nected to the spectrometer, while the two source fiber bundles 
were connected to the tamp via an on-axis, or off-axis orien-
tation. Computer controlled shutter system 110 was placed in 
front of the lamp to switch between the two source fiber 
positions so that only a single source fiber bundle was illumi-
nated by the lamp. 
Reflectance spectra collected at the short distance (2.5 mm 
SD) captured information from substantially only the skin 
and fat layers of the phantoms. Spectra collected at the long 
distance (30 mm SD) included spectral information from the 
skin, fat, and muscle layers. 
Phantoms were separated into calibration and test sample 
sets. Samples in the calibration set were chosen with proper-
ties that were different from those in the calibration set to test 
PLS model predictions on samples which may have been 
poorly and/or incompletely modeled during calibration. Spe-
cifically, phantoms with a fat thickness of 2.0 mm and various 
dye concentrations and muscle scattering coefficients (a total 
of 27 phantoms) were used as the test samples. The remaining 
samples (a total of 54 phantoms) with fat thicknesses of 4.0 
mm or 6.0 mm for each of the various dye concentrations and 
muscle scattering coefficients were used for calibration. None 
of the calibration samples had a fat layer with a thickness of 
2.0 mm, and none of the test samples had a fat layer with a 
thickness of 4.0 mm or 6.0 mm. 
A PLS model for dye concentration in the phantom muscle 
was created using calibration sample data, and the model was 
validated by predicting muscle dye concentrations from test 
sample spectra. Leave-one-out cross-validation was used to 
determine the number of PLS model factors. To evaluate the 
various spectral correction methods, PLS regressions were 
performed with and without PCA loading corrections and/or 
short-distance corrections and/or SNV scaling corrections. 
Data within a spectral wavelength range from 700 nm to 900 
mu was used in the analysis. Prediction accuracy of the PLS 
models was described by R 2 (the coefficient of determination) 
between the estimated and actual dye concentrations, and an 
estimated measurement error, which was calculated as a root 
mean squared error of prediction (RMSEP) according to: 
RMSEP =[(i1Mx~ .N(9,-y,)2] 112 	 (6) 
where N is a number of test samples, and y, and y, are the 
estimated and actual dye concentrations. A large R 2 value and 
a low RMSEP indicate that the PLS model accurately predicts 
dye concentration in the phantom samples. 
Various spectral correction and data analysis algorithms 
were implemented in programs written in version 7.0 of the 
MatlabTM programming language (available from The Math-
works Inc., Natick, Mass.) and the version 3.5 of PLS_Tool-
boxTM (available from Eigenvector Research Inc., Manson, 
Wash.). 
In the following examples, where short-distance correc-
tions are applied to reflectivity spectra in combination with 
other spectral correction methods, the short-distance correc-
tions are applied first. Where PCA loading corrections are 
applied to reflectivity spectra in combination with other spec-
tral correction methods, the PCA loading corrections are 
applied last. For example, where short-distance, SNV, and 
PCA loading corrections are applied to spectral data, the 
short-distance corrections are applied first, followed by the 
SNV corrections, and finally the PCA loading corrections are 
applied. 
Six calibration samples with the same dye concentration 
(e.g., n=6) were used to obtain PCA loadings for PCA loading 
correction of spectral data. The dye concentration at which 
the PCA loadings were obtained will be referred to as the 
5 "calibration" dye concentration subsequently. Loadings were 
obtained from PCA on sets of six calibration samples, with 
each set of six samples having one of nine different selected 
dye concentrations. Reflectance spectra for each set of six 
samples were corrected using different combinations of spec- 
io tral correction methods to examine the effect of the methods 
and their parameters on the calculated loading vectors. To 
determine the number of loading vectors used in PCA loading 
correction, leave-one-out cross-validation calibration proce-
dures were used in PLS models for dye concentration in the 
15 phantom samples. Calibration was performed using 1, 2, 3, 4, 
and 5 PCA loading vectors at each of the selected dye con-
centrations. The number of loading vectors and the selected 
dye concentration which produced the smallest root mean 
squared error of cross-validation (RMSECV) were selected 
20 for evaluation of the spectral correction methods. Analysis of 
the phantoms determined that the first four loading vectors 
obtained from PCA on the calibration spectra with a dye 
concentration of 20.22 µg/mL, provided the best prediction 
results for the test samples. The three spectral correction 
25 methods short-distance overlayer correction, SNV correc-
tion, and PCA loading correction were compared individu-
ally and in combination under the above conditions. 
FIG. 18 shows an absorption spectrum of theADS78OWS 
dye in aqueous solution. FIGS. 19 and 20 show phantom 
3o absorbance spectra for short distance (e.g., 2.5 mm) and long 
distance (e.g., 30 mm) illumination of the phantoms, respec-
tively. FIG. 21 shows long distance absorbance spectra cor-
rected by applying short-distance correction methods, as dis-
cussed previously. The short distance absorbance spectra in 
35 FIG. 19 include reflected light from only the skin and fat 
layers overlying the muscle layer in the phantoms. The down-
ward-sloping shapes of the absorbance curves are character-
istic of the absorber melanin in the skin layer. Further, base-
line shifts among the various curves are due to different fat 
40 layer thicknesses among the various phantoms. 
Long distance spectra in FIG. 20 have spectral shapes that 
are similar to the dye solution spectrum shown in FIG. 18. The 
long distance spectra include contributions from light 
reflected from phantom muscle layers, where the dye is 
45 located. Variations in absorbance, e.g., between 700 nm and 
750 nm, are due to a superposition of skin absorption and fat 
and muscle scattering effects on the dye absorption. Short-
distance corrections reduce and/or remove skin absorption 
and fat scattering effects from the spectral absorbance data. 
5o As shown in FIG. 21, the resulting corrected spectra are more 
nearly coincident and resemble more closely the spectrum 
shown in FIG. 18 than the uncorrected spectra in FIG. 20. 
However, baseline variations that are attributed to variations 
in optical properties of the muscle layer (e.g., variability in 
55 muscle layer scattering) between samples. PCA loading cor-
rection algorithms can be used to reduce or remove variations 
that arise from the non-uniformity of the optical properties of 
the muscle layer among the phantoms. 
FIGS. 22-27 show absorbance spectra of six calibration 
60 samples, each with dye concentration 20.22 µg/mL, but with 
different combinations of fat layer thickness (4.0 mm or 6.0 
mm) and muscle scattering coefficient (0.5 mm - ', 0.65 
mm- ', or 0.8 mm- '). FIG. 22 shows uncorrected absorbance 
spectra. If spectral effects due to fat and muscle scattering and 
65 skin absorption were perfectly corrected among the various 
phantoms, spectra corresponding to the same dye concentra- 
tion would be overlapped. In the spectra shown in FIG. 22, 
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some baseline shift and flattening is observed between 700 
mu and 800 mu, and is attributable to these scattering and 
absorption effects. 
FIG. 23 shows spectra from FIG. 22 after short-distance 
corrections for the overlying skin and fat layers have been 
applied to the spectra. The corrected spectra are closer to one 
another as a result of the applied correction, and have shapes 
that more closely resemble the absorption band of FIG. 18. 
However, there are still some differences among the corrected 
spectra, e.g., in the spectral region near the absorption peak at 
about 780 mu. These variations arise from muscle layer scat-
tering, which is not corrected by short-distance algorithms 
and methods. 
FIG. 24 shows spectra from FIG. 22 after SNV scaling 
corrections have been applied. The spectra are closer together 
following application of the SNV methods, but a relatively 
flat shape of the spectra indicates that skin and fat absorption 
and scattering are not corrected by the SNV methods alone. In 
general, SNV methods can be used to reduce and/or remove 
scattering differences among multiple samples when varia-
tion among sample spectra arises primarily from scattering, 
rather than analyte variation. 
FIG. 25 shows spectra from FIG. 22 after PCA loading 
corrections have been applied to the spectra. Four loadings 
obtained from PCA of calibration samples with dye concen-
trations of 20.22 ltg/mL were used to correct the absorbance 
spectra shown in FIG. 22. The corrected spectra, shown in 
FIG. 25, are closer together than the original uncorrected 
spectra. However, the corrected spectra still show spectral 
features that are attributable to melanin absorption in the skin 
layer of the samples. 
Combinations of the various correction methods can also 
be applied to the absorbance spectra. FIG. 26 shows spectra 
from FIG. 22 after short-distance corrections and then SNV 
scaling corrections were applied in succession. Compared 
with the short-distance-corrected spectra of FIG. 23, the spec-
tra in FIG. 26 are closer together and baseline variations are 
reduced, but are still present. 
FIG. 27 shows spectra from FIG. 22 after short-distance 
corrections, SNV scaling corrections, and PCA loading cor-
rections were applied in succession. The spectra in FIG. 27 
are highly overlapped, and their shapes resemble relatively 
closely the dye spectrum shown in FIG. 18 in the short wave-
length region from 700 mu to 780 mu. Application of all three 
correction methods to the spectral absorbance data signifi-
cantly reduced spectral contributions from skin and fat layer 
absorption and scattering, and different muscle scattering 
coefficients arising from analyte-irrelevant variations in opti-
cal properties of the muscle layer. 
PLS predictive models were constructed based on calibra-
tion data and used to predict values of dye concentration in 
test samples. Spectral absorbance data for the calibration and 
test samples was either uncorrected, or corrected by applying 
short-distance corrections only, SNV scaling corrections 
only, PCA loading corrections only, a combination of short-
distance and SNV scaling corrections, a combination of 
short-distance and PCA loading corrections, a combination 
of SNV scaling and PCA loading corrections, or a combina-
tion of short-distance, SNV scaling, and PCA loading correc-
tions. A summary of model prediction results is shown in 
Table 4. Each PLS model has large values of R 2 (equal to or 
greater than 0.95), indicating that a strong correlation exists 
between predicted and measured dye concentrations. Without 
any spectral processing, even though predicted and measured 
dye concentrations were highly correlated, large prediction 
30 
errors resulted: the RMSEP was 4.31 ltg/mL, corresponding 
to an error of 21.54% of the total concentration range (from 
26.68 ltg/mL to 6.67 ltg/mL). 
With short-distance corrections only, SNV scaling correc- 
5 tions only, or PCA loading corrections only, the RMSEP of 
the PLS model decreased. Combinations of two different 
correction methods further decreased the RMSEP of the PLS 
model, and combining all three correction methods resulted 
in a PLS model with the lowest RMSEP, 1.08 ltg/mL, a 5.3% 
10 percentage error, and a 3-fold decrease in RMSEP relative to 
a PLS model where no correction methods were used. 
TABLE 4 
15 Spectral Correction 	 RMSEP 	 Percentage 	 Number 
Methods 	 R' 	 (µg/mL) 	 Error 	 of Factors 
None 0.96 4.31 21.5 7 
Short-Distance Only 0.97 3.86 19.3 7 
SNV Scaling Only 0.97 3.16 15.8 2 
PCA Loading Only 0.95 3.66 18.3 6 
20 	 Short-Dist. + SNV 0.96 2.55 12.7 2 
Short-Dist. + PCA 0.96 2.69 13.4 3 
SNV + PCA 0.97 1.88 9.4 6 
Short-Dist. SNV +PCA 0.97 1.08 5.3 4 
25 	 In certain embodiments, using spectral correction methods 
can reduce a number of factors used in a PLS model. For 
example, when PCA loading corrections were used along or 
in combination with the other correction methods, the number 
of model factors was less than the 7 factors used in a model 
30 based on uncorrected spectral absorbance data. As an 
example, when the three correction methods were used in 
combination, the PLS model for dye concentration in the 
muscle layer of samples used 4 model factors. This reduction 
in the number of factors for the concentration model was 
35 achieved because correction of the spectral data removed 
variations due to skin color, fat layer thickness, and muscle 
layer optical properties that would otherwise have been mod-
eled with PLS regression. 
Model prediction results are shown in FIG. 28 with no 
40 correction of the spectra absorbance data, and in FIG. 29 with 
correction of the spectral data using a combination of short-
distance, SNV scaling, and PCA loading corrections. The 
diagonal line in each figures represents perfect prediction. 
Comparing FIGS. 28 and 29, after correcting the spectra data 
45 using three different correction methods, prediction results 
are more closely clustered along the diagonal unity line, and 
the predictive value of the PLS model is greater. 
Example 5 
50 
The spectral correction methods disclosed herein have also 
been applied to human tissue spectra. For example, where 
spectra corresponding to different subjects, each having the 
same value of a particular analyte of interest are available, 
55 PCA loading corrections can be used to improve PLS models 
based on the spectra. As an example, a range of pH values can 
be obtained for a subject during periods of exercise. In gen-
eral, muscle and blood pH decreases during exercise as lactic 
acid is produced, and then pH returns rapidly to baseline 
60 values when exercise is halted. If absorbance spectra are 
recorded continuously during periods of exercise and muscle 
and/or blood pH is simultaneously monitored, it is possible to 
obtain spectral data at different times that corresponds to the 
same pH value from different subjects performing a similar 
65 exercise protocol. 
To evaluate the PCA loading correction method on spectral 
data from human subjects, a set of spectra and blood pH 
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measurements were collected from the forearms of three 
human subjects performing a repetitive handgrip exercise 
protocol. Each subject squeezed a test device for 4 seconds, 
then relaxed for 2 seconds, repeating this pattern for a total 
duration of 5 minutes. Each subject performed four different 5 
exercise protocols at different, successively increasing force 
levels, with a 30 minute rest period between each protocol. 
FIG. 30 shows a set of absorbance spectra collected from 
the three human subjects at time points during the exercise 
protocols where the blood pH of each subject was io 
7.37±0.001. Short-distance and SNV scaling corrections 
have been applied to the set of spectral data. FIG. 31 shows 
the same set of absorbance spectra shown in FIG. 30 after 
PCA loading corrections have been further applied. The 
absorbance spectra in FIG. 31 have been orthogonalized with 15 
the first four loading vectors obtained from PCA of the spec-
tra in FIG. 30. After PCA loading correction of the spectral 
data, spectra from different subjects were significantly more 
overlapped, indicating that spectral contributions due to opti-
cal property variations in muscle tissues from one subject to 20 
another, which were not correlated with pH, were signifi-
cantly reduced. 
FIG. 32 shows all of the spectra from each of the three 
human subjects during periods of exercise at all measured pH 
values. Short-distance and SNV scaling corrections have 25 
been applied to the spectral data. FIG. 33 shows the data from 
FIG. 32 after PCA loading corrections have been further 
applied. The data was orthogonalized with the first four load-
ing vectors obtained from PCA of the calibration spectra in 
FIG. 30 that correspond to a pH of 7.37±0.001. Application of 30 
PCA loading corrections significantly reduced variations in 
the spectra due to subject-to-subject variations in muscle 
tissue optical properties. Variations among the spectra shown 
in FIG. 33 correspond nominally to absorbance variations 
resulting from exercise-induced changes in muscle pH levels. 35 
Other Embodiments 
It is to be understood that while the invention has been 
described in conjunction with the detailed description 40 
thereof, the foregoing description is intended to illustrate and 
not limit the scope of the invention, which is defined by the 
scope of the appended claims. Other aspects, advantages, and 
modifications are within the scope of the following claims. 
What is claimed is: 	 45 
1. A measurement system comprising: (a) a plurality of 
light emitting diodes (LEDs) adapted to transmit light to an in 
vivo sample comprising skin, fat, and muscle; (b) a detection 
system adapted to receive light reflected from the sample, 
wherein the detection system generates a first data set corre- 50 
sponding to a first detection distance and comprising spectral 
absorbance or reflectance values corresponding to both 
muscle within the sample and skin and fat overlying the 
muscle, and a second data set corresponding to a second 
detection distance and comprising spectral absorbance or 55 
reflectance values corresponding to skin and fat overlying the 
muscle; and (c) a processor adapted to use spectral absor-
bance or reflectance values characteristic of the skin and fat 
from the first data set and the second data set to produce 
corrected spectral absorbance or reflectance values represent- 60 
ing the muscle, wherein the processor is adapted to normalize 
the first and second data sets prior to producing the corrected 
spectral absorbance or reflectance values.  
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2. The measurement system of claim 1, wherein the plu-
rality of LEDs are combined to provide light having wave-
lengths corresponding to regions of the electromagnetic spec-
trum selected from the group consisting of infrared region, 
near infrared region, visible region, and combinations 
thereof. 
3. The measurement system of claim 1, wherein the plu-
rality of LEDs comprises LEDs having different emission 
properties selected from the group consisting of wavelength 
and intensity. 
4. The measurement system of claim 3, wherein the plu-
rality of LEDs are configured to provide light in multiple 
regions of the electromagnetic spectrum at the same time. 
5. The measurement system of claim 1, wherein the plu-
rality of LEDs comprises a first array of LEDs. 
6. The measurement system of claim 5, wherein the plu-
rality of LEDs further comprises a second array of LEDs. 
7. The measurement system of claim 1, wherein the detec-
tion system comprises a spectrometer. 
8. The measurement system of claim 7, wherein the spec-
trometer is adapted to generate sets of spectra from the 
reflected light. 
9. A method for correcting information corresponding to a 
target within an in vivo sample comprising skin, fat, and 
muscle, the method comprising the steps of: illuminating the 
sample with at least one light emitting diode (LED); detecting 
light reflected from the sample; generating a first data set 
corresponding to a first detection distance and comprising 
spectral absorbance or reflectance values corresponding to 
both muscle within the sample and skin and fat overlying the 
muscle, and a second data set corresponding to a second 
detection distance and comprising spectral absorbance or 
reflectance values corresponding to skin and fat overlying the 
muscle; normalizing the first and second data sets; and using 
spectral absorbance or reflectance values characteristic of the 
skin and fat from the normalized first data set and the normal-
ized second data set to produce corrected spectral absorbance 
or reflectance values representing the muscle. 
10. The method of claim 9, wherein the illuminating step 
comprises using a plurality of LEDs. 
11. The method of claim 10, wherein the plurality of LEDs 
are combined to provide light having wavelengths corre-
sponding to regions of the electromagnetic spectrum selected 
from the group consisting of infrared region, near infrared 
region, visible region, and combinations thereof. 
12. The method of claim 10, wherein the plurality of LEDs 
comprises LEDs having different emission properties 
selected from the group consisting of wavelength and inten-
sity. 
13. The method of claim 12, wherein the plurality of LEDs 
are configured to provide light in multiple regions of the 
electromagnetic spectrum at the same time. 
14. The method of claim 10, wherein the plurality of LEDs 
comprises a first array of LEDs. 
15. The method of claim 14, wherein the plurality of LEDs 
further comprises a second array of LEDs. 
16. The method of claim 9, wherein the reflected light is 
detected with a spectrometer. 
17. The method of claim 16, wherein the spectrometer is 
configured to generate sets of spectra from the reflected light. 
